Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
277,487,877
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
109,280,872
-
Shares change
-
+109,194,872
-
Total reported value, excl. options
-
$2,919,429,193
-
Value change
-
+$2,917,131,238
-
Number of buys
-
114
-
Price
-
$26.72
Significant Holders of Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI) as of Q2 2025
117 filings reported holding CAI - Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share as of Q2 2025.
Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 109,280,872 shares
of 277,487,877 outstanding shares and own 39.38% of the company stock.
Largest 10 shareholders include Sixth Street Partners Management Company, L.P. (24,385,399 shares), COATUE MANAGEMENT LLC (10,142,198 shares), FMR LLC (8,631,545 shares), BRAIDWELL LP (7,316,142 shares), T. Rowe Price Investment Management, Inc. (7,303,987 shares), PRICE T ROWE ASSOCIATES INC /MD/ (6,760,804 shares), NEUBERGER BERMAN GROUP LLC (6,239,520 shares), Silver Lake Group, L.L.C. (5,291,006 shares), MILLENNIUM MANAGEMENT LLC (3,513,176 shares), and ORBIMED ADVISORS LLC (3,034,858 shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.